4LEN
CTX-M-9 in complex with the broad spectrum inhibitor 3-(2- carboxyvinyl)benzo(b)thiophene-2-boronic acid
Summary for 4LEN
Entry DOI | 10.2210/pdb4len/pdb |
Descriptor | Beta-lactamase, (2E)-3-[2-(dihydroxyboranyl)-1-benzothiophen-3-yl]prop-2-enoic acid (3 entities in total) |
Functional Keywords | binding sites, structure base drug design, drug discovery, molecular, enzyme inhibitors, beta lactamases, boronic acids, broad spectrum, bacterial resistance, double perturbation cycle analysis, thermodynamics, structure activity relationship, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Escherichia coli |
Total number of polymer chains | 2 |
Total formula weight | 56441.11 |
Authors | Tondi, D. (deposition date: 2013-06-26, release date: 2014-06-18, Last modification date: 2023-09-20) |
Primary citation | Tondi, D.,Venturelli, A.,Bonnet, R.,Pozzi, C.,Shoichet, B.K.,Costi, M.P. Targeting Class A and C Serine beta-Lactamases with a Broad-Spectrum Boronic Acid Derivative. J.Med.Chem., 57:5449-5458, 2014 Cited by PubMed: 24882105DOI: 10.1021/jm5006572 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.5 Å) |
Structure validation
Download full validation report